Compare CGEM & VTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEM | VTEX |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.7M | 710.7M |
| IPO Year | 2021 | 2021 |
| Metric | CGEM | VTEX |
|---|---|---|
| Price | $10.19 | $3.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $28.00 | $6.96 |
| AVG Volume (30 Days) | ★ 1.2M | 744.6K |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.40 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $234,115,000.00 |
| Revenue This Year | N/A | $9.00 |
| Revenue Next Year | N/A | $13.06 |
| P/E Ratio | ★ N/A | $52.77 |
| Revenue Growth | N/A | ★ 3.65 |
| 52 Week Low | $5.68 | $3.63 |
| 52 Week High | $13.33 | $6.93 |
| Indicator | CGEM | VTEX |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 33.51 |
| Support Level | $9.41 | $3.64 |
| Resistance Level | $10.70 | $3.81 |
| Average True Range (ATR) | 0.61 | 0.10 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 40.66 | 11.29 |
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.